“Does the Response to Morning Medication Predict the ADL-Level of the Day in Parkinson’s Disease?”

Table 2

Overview of the two groups with the EQ-doses included.

Groups	Total EQ-dose mean (sd)	EQ-Levodopa mean (sd)	EQ-agonist mean (sd)	UPDRS-score mean (sd)	BKS-change mean (sd)	Years of PD-duration mean (sd)
Gr.1 + 2	607,5 (207, 3)	328,8 (198, 8)	255,1 (187, 2)	10,5 (4, 7)	27,9 (24,5)	5,0 (2, 3)
Gr. 1	500,1 (142, 4)	264,9 (178, 4)	173,6 (131, 2)	7,4 (2, 3)	−43,7 (28,4)	4,7 (1, 6)
Gr. 2	692,3 (163, 5)	359,6 (171, 6)	162,2 (106, 3)	13 (5, 1)	−15,4 (3, 8)	5,3 (2, 2)
-values	0,006	0,003	0,761	0,0002	0,0052	0,063

Group 1 = Good responders. Group 2 = Poor responders. Low score in UPDRS-II indicates less ADL-impairments. Cut-off value between poor and good responders.